A virtual first

Sitari Pharmaceuticals Corp. is the first of what partners Avalon Ventures and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) expect will be several virtual newcos formed over the next year under an April deal designed to populate GSK's pipeline with programs translated from early stage academic projects.